2020
Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance
Kunst N, Long JB, Xu X, Busch SH, Kyanko KA, Richman IB, Gross CP. Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance. JAMA Internal Medicine 2020, 180: 799-801. PMID: 32202606, PMCID: PMC7147248, DOI: 10.1001/jamainternmed.2020.0262.Peer-Reviewed Original Research
2013
Cost-effectiveness of endometrial evaluation prior to morcellation in surgical procedures for prolapse
McPencow AM, Erekson EA, Guess MK, Martin DK, Patel DA, Xu X. Cost-effectiveness of endometrial evaluation prior to morcellation in surgical procedures for prolapse. American Journal Of Obstetrics And Gynecology 2013, 209: 22.e1-22.e9. PMID: 23545164, DOI: 10.1016/j.ajog.2013.03.033.Peer-Reviewed Original ResearchConceptsIncremental cost-effectiveness ratioEndometrial biopsyTransvaginal ultrasoundCost-effectiveness ratioPostmenopausal womenEndometrial cancerEndometrial evaluationScreening optionsInvasive sacral colpopexyRisk of upstagingPelvic organ prolapseCancer upstagingSupracervical hysterectomySacral colpopexyCancer prevalenceOrgan prolapsePatient costsPreoperative detectionSurgical proceduresUniversal screeningBiopsyMorcellationCancerUltrasoundUpstaging